A key scientist in one of the earliest examples of structure-based drug design, Peter Colman reflects on work to describe the influenza virus protein neuraminidase and discusses the challenges facing ongoing efforts to expand the portfolio of anti-influenza drugs.
Dave Sammut and Chantelle Craig report on the history and emerging applications of an element with a controversial past and strategic future.
Hawking was a determined and stubborn person. This could make him very difficult to work with, but it could also push research projects forward.
We know Hawking thought something called ‘M-theory’ is our best bet for a complete theory of the universe. But what is it?